AVE vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

55MEDIUM

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

AVE EYE
Technical
55
46
Catalyst
59
54
Sentiment
50
50
Fundamental
44
60
Momentum
71
65
Risk Gate
45
50

Key Metrics

AVE Metric EYE
$77.3MMarket Cap$38.5M
3.9MAvg Volume (20d)199K
N/AShort InterestN/A
$0.02752-Week High$0.205
$0.00552-Week Low$0.100
-4.6%Daily Change+3.8%
$0.021Reference Price$0.135
-268.2%ROE-26.1%
N/AProfit Margin-12.4%

Active Signals

AVE Signals

●Drifting lower — down 8.7% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (104.8x)
●Revenue in sharp decline (-89%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

Ask Scout AI to compare AVE and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs CGS →CGS vs IIQ →CGS vs LDX →CGS vs LGP →EYE vs SOM →
AVE Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).